Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-

Balchem Corporation - Close Out Letter 8/18/10

 

Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
 Chicago District
550 West Jackson Blvd.,
15th Floor
Chicago, Illinois 60661
Telephone: 312-353-5863

 

August 18, 2010

Mr. Dino Rossi, President and CEO
Balchem Corporation
52 Sunrise park Road
New Hampton, New York 10958

Dear Mr. Rossi:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter CHI-02-10. Based on our evaluation (which includes the follow-up inspection of July 12 - July 21, 2010), it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,

/s/

Scott J. MacIntire
Chicago District Director

-
-